| Zeus Markos, LCSW | |
|
257 South St, Biddeford, ME 04005-2154 | |
| (207) 309-8568 | |
| Not Available |
| Full Name | Zeus Markos |
|---|---|
| Gender | Male |
| Speciality | Social Worker - Clinical |
| Location | 257 South St, Biddeford, Maine |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154086874 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | LC22895 (Maine) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Zeus Markos, LCSW Po Box 311, Kennebunk, ME 04043-0311 Ph: (207) 200-4947 | Zeus Markos, LCSW 257 South St, Biddeford, ME 04005-2154 Ph: (207) 309-8568 |
News Archive
The "one-size-fits-all, Washington-based approach" to overhauling the U.S. health care system "is wrong" and, instead, reform should focus on providing a "patient-centered health care system that gives consumers direct control and choice over their health care decisions," Rep. Tim Walberg (R-Mich.) writes in a Washington Times opinion piece.
A major breakthrough in how to target and destroy the most malignant and aggressive brain cancer cells has been made by researchers at Wake Forest University Baptist Medical Center.Scientists have identified a way to target and destroy Glioblastoma multiforme (GBM) cells without harming healthy cells.
News outlets report on various developments related to the implementation of the health law.
GOJO Industries, a leader in hand hygiene and skin health and inventors of PURELL- Hand Sanitizer, conducted an independent research study at the John Peter Smith Hospital in Fort Worth, Texas to determine the impact on hand hygiene compliance rates when the hospital hand hygiene program included an electronic compliance activity monitoring system.
Kamada Ltd. (NASDAQ:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announces the initiation of a Phase 2/3 clinical trial of Glassia®, the Company's proprietary human Alpha-1 Antitrypsin (AAT), to treat newly diagnosed pediatric patients with type 1 diabetes (T1D).
› Verified 7 days ago
Daniela Mason, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2 Springbrook Dr, Biddeford, ME 04005 Phone: 207-282-1500 Fax: 207-282-2581 | |
Mr. Matthew Edward Wells, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 2 Springbrook Dr, Biddeford, ME 04005 Phone: 207-282-1500 Fax: 207-282-2581 | |
Lynn I Watson, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 10 May St, Biddeford, ME 04005 Phone: 207-205-2560 Fax: 207-284-7861 | |
Ms. Virginia Deluca, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 497 Elm St, Biddeford, ME 04005 Phone: 180-045-5872 | |
Amber L Silva, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 24 State St Apt 37, Biddeford, ME 04005 Phone: 207-922-4600 Fax: 207-294-4649 | |
Timothy Fuller, LMSW-CC Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 314 Alfred St, Biddeford, ME 04005 Phone: 207-216-2637 | |
Ms. Patricia A Burke, MSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 411 Alfred St, Biddeford, ME 04005 Phone: 207-625-7012 |